1.
Genetic architecture of resilience of executive functioning.
by Mukherjee, Shubhabrata
Brain imaging and behavior, December 2012, Vol.6(4), pp.621-633

2.
Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity
by Neda Jahanshad
Proceedings of the National Academy of Sciences, 19 March 2013, Vol.110(12), p.4768

3.

4.
Predicting AD conversion: comparison between prodromal AD guidelines and computer assisted PredictAD tool.
by Liu, Yawu
PloS one, 2013, Vol.8(2), p.e55246

5.
Plasma based markers of [11C] PiB-PET brain amyloid burden.
by Kiddle, Steven John
PloS one, 2012, Vol.7(9), p.e44260

6.
Rates of decline in Alzheimer disease decrease with age.
by Holland, Dominic
PloS one, 2012, Vol.7(8), p.e42325

7.
Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease.
by Reitz, Christiane
PloS one, 2012, Vol.7(12), p.e50354

8.
Improved classification of Alzheimer's disease data via removal of nuisance variability.
by Koikkalainen, Juha
PloS one, 2012, Vol.7(2), p.e31112

9.
Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease.
by Wolz, Robin
PloS one, 2011, Vol.6(10), p.e25446

10.

11.
Classification of structural MRI images in Alzheimer's disease from the perspective of ill-posed problems.
by Casanova, Ramon
PloS one, 2012, Vol.7(10), p.e44877

12.
Vascular burden and Alzheimer disease pathologic progression
by Lo, Y., Raymond
Neurology, 2012, Vol.79(13), pp.1349-1355

13.
18F-florbetapir Positron Emission Tomography–determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery
by Klinger, Y., Rebecca
Anesthesiology, 2018, Vol.128(4), pp.728-744

14.
Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease.
by Li, Rui
PloS one, 2014, Vol.10(4), p.e0122731

15.
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
by Habeck, Christian
Brain imaging and behavior, December 2012, Vol.6(4), pp.568-583

16.
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
by Cruchaga, Carlos
Neuron, April 24, 2013, Vol.78(2), pp.256-268

17.
Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.
by Nho, Kwangsik
Brain imaging and behavior, December 2012, Vol.6(4), pp.551-567

18.
The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.
by Skinner, Jeannine
Brain imaging and behavior, December 2012, Vol.6(4), pp.489-501

19.
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease.
by Ewers, Michael
Neurobiology of aging, August 2012, Vol.33(8), pp.1599-1608

20.
Periventricular hyperintensities are associated with elevated cerebral amyloid.
by Marnane, Michael
Neurology, February 9, 2016, Vol.86(6), pp.535-543
